CORT – corcept therapeutics incorporated (US:NASDAQ)
Stock Stats
News
Levi & Korsinsky, LLP Notifies Shareholders of Corcept Therapeutics Incorporated (CORT) an Upcoming Claims Deadline in a Class Action Settlement
Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target raised by analysts at HC Wainwright from $38.00 to $40.00. They now have a "buy" rating on the stock.
Corcept (CORT) Q1 Earnings & Revenues Surpass Estimates [Yahoo! Finance]
Levi & Korsinsky, LLP Notifies Shareholders of Corcept Therapeutics Incorporated (CORT) an Upcoming Claims Deadline in a Class Action Settlement
Form 4 CORCEPT THERAPEUTICS For: May 02 Filed by: Lyon Joseph Douglas
Form 4 CORCEPT THERAPEUTICS For: May 01 Filed by: Swisher Daniel N JR
Form 10-Q CORCEPT THERAPEUTICS For: Mar 31
Form 8-K CORCEPT THERAPEUTICS For: May 01
Form 144 CORCEPT THERAPEUTICS Filed by: Swisher Daniel N JR
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.